You are here

Guinea

Ebola Now Preoccupies Once-Skeptical Leader in Guinea

NEW YORK TIMES -- BY Adam Nossiter                                                                    Dec. 1, 2014                          
Description of the way that President Alpha Conde, after intially minmizing the Ebola threat, "is mustering a late-career tenacity to confront the deadly epidemic that still infects hundreds in this battered West African nation."

                            “While shaving I think of Ebola, while eating I think of Ebola,” said President Alpha Condé of Guinea. The response of nearby nations helped galvanize Mr. Condé. Credit Samuel Aranda for The New York Times

Read complete story:

http://www.nytimes.com/2014/12/01/world/africa/ebola-now-preoccupies-once-skeptical-leader-in-guinea.html?hp&action=click&pgtype=Homepage&module=second-column-region&region=top-news&WT.nav=top-news&_r=0

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

There Is An Urgent Need For An Improved Infrastructure To Share Health Data, Researchers Say

DESIGN & TREND  by Randall Mayes                                                                             Nov. 29, 2014

Over the last decade, we have witnessed the emergence of Superbugs, various strains of bird flu and now Ebola, which do not have geographical borders.

Consequently, there is a pressing need for international cooperation to control these pandemics.

In a new study, researchers have identified obstacles that are currently preventing the world from sharing health data, reports Science Daily.

While performing a literature search for the study, an international group of researchers discovered over 1,400 scientific articles related to sharing public health data. From those articles, they found two broad categories that need to be addressed.

Read comlete story
http://www.designntrend.com/articles/28008/20141129/urgent-need-improved-infrastructure-share-health-data.htm

Link to article  in Science Daily
http://www.sciencedaily.com/releases/2014/11/141125102102.htm

General Topic Tags: 
Problem, Solution, SitRep, or ?: 

WHO advises male Ebola survivors to abstain from sex

REUTERS                                                                                                                      NOV. 28, 2014

LONDON --Men who recover from Ebola should abstain from sex for three months to minimize the risk of passing the virus on in their semen, the World Health Organization (WHO) said on Friday.

Ebola, a disease that has infected and killing thousands in a vast epidemic in West Africa, normally spreads via bodily fluids such as blood, saliva and faeces. Although sexual transmission of Ebola virus disease has never been documented, the virus has been detected in the survivors' semen.

"Men who have recovered from Ebola virus disease should be aware that seminal fluid may be infectious for as long as three months after onset of symptoms," the WHO said in a statement....

Read complete story
http://www.reuters.com/article/2014/11/28/us-health-ebola-sex-idUSKCN0JC0UP20141128

Country / Region Tags: 
General Topic Tags: 
Problem, Solution, SitRep, or ?: 

Ebola aid dogged by coordination lags in Guinea

ASSOCIATED PRESS  By MICHELLE FAUL and JAMEY KEATEN Nov. 27, 2014

CONAKRY, Guinea --   ...President Alpha Conde says his government must coordinate the  (expected French)  response, one that aid workers say is confusing and inefficient. Overall the responsibility for the crisis has changed hands several times, from WHO’s regional Africa office, to its headquarters and finally to the U.N. mission.

“It’s difficult for us to understand who is working for (which) WHO” - the local Africa division or the central office in Geneva, said Pascal Piguet, a logistics expert with Doctors Without Borders who leads the Ebola treatment center in the southern town of Gueckedou....

Oyewale Tomori, a professor of virology at Redeemer’s University in Nigeria who sits on WHO’s emergency committee on Ebola, said countries themselves should be coordinating the Ebola control efforts with help from agencies like the U.S. CDC and WHO. “But that’s not happening. We have a very fractured response,” Tomori added....

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Ebola crisis: French President Hollande to visit Guinea

French President Francois Hollande is to arrive in Guinea, becoming the first Western leader to visit a nation hit hard by the deadly Ebola virus.

He will deliver "a message of solidarity" to Guinea, where more than 1,200 have died of Ebola.

Meanwhile Guinea is to trial a new Ebola test that will deliver results six times faster than current methods.

The outbreak was now "stable" in the West African country, the World Health Organization (WHO) said last week.

France has pledged 100m euros (£79m; $125m) to help tackle the disease by opening several care centres in Guinea, a former French colony.

Read complete story
http://www.bbc.com/news/world-africa-30241374

Country / Region Tags: 
General Topic Tags: 
Problem, Solution, SitRep, or ?: 

Despite Aid Push, Ebola Is Raging in Sierra Leone

NEW YORK TIMES   By Jeffrey Gettleman                        Nov.28, 2014

KISSI TOWN, Sierra Leone-- ...While health officials say they are making headway against the Ebola epidemic in neighboring Liberia, the disease is still raging in Sierra Leone, despite the big international push. In November alone, the World Health Organization has reported more than 1,800 new cases in this country, about three times as many as in Liberia, which until recently had been the center of the outbreak....

On Freetown’s outskirts, burly youth are setting up roadblocks. The police are nowhere to be found. The young men barricade the road brandishing digital thermometers. Credit Daniel Berehulak for The New York Times

Country / Region Tags: 
General Topic Tags: 
Problem, Solution, SitRep, or ?: 

Scientists: 'Positive' results in 1st human trial of experimental Ebola vaccine

CNN -- By Laura Smith-Spark                              Nov. 27, 2014

The first human trial of an experimental Ebola vaccine has produced promising results, U.S. scientists said, raising hopes that protection from the deadly disease may be on the horizon.

All 20 healthy adults who received the vaccine in a trial run by researchers from the National Institutes of Health in Maryland produced an immune response and developed anti-Ebola antibodies, the NIH said Wednesday.

None suffered serious side effects, although two people developed a brief fever within a day of vaccination.

The vaccine is being developed by the NIH's National Institute of Allergy and Infectious Diseases and British pharmaceutical giant GlaxoSmithKline. The process has been fast-tracked in light of the current catastrophic Ebola outbreak in West Africa, which has claimed more than 5,000 lives.

http://www.cnn.com/2014/11/27/health/ebola-outbreak/

General Topic Tags: 
Problem, Solution, SitRep, or ?: 

Ebola discoverer Piot sees long, bumpy road to ending epidemic

REUTERS      By Kate Kelland                                                                                                  Nov. 26, 2014

LONDON --West Africa's Ebola epidemic could worsen further before abating but new infections should start to decline in all affected countries by the end of this year, a leading specialist on the disease said on Wednesday.

Peter Piot, one of the scientists who first identified the Ebola virus almost 40 years ago, said the outbreak was far from over, but said that "thanks to now massive efforts at all levels" what had been an exponential growth in numbers should soon begin to recede.

The death toll in the worst Ebola epidemic on record has risen to 5,459 out of 15,351 cases identified in eight countries by November 18, latest data from the World Health Organization (WHO) showed. Almost all those cases are in Guinea, Sierra Leone and Liberia.

"By the end of the year we should start seeing a real decline everywhere," Piot, who is now director of the London School of Hygiene and Tropical Medicine, told a meeting of public health experts, non-governmental organizations and officials.

http://www.reuters.com/article/2014/11/26/us-health-ebola-piot-idUSKCN0JA1AQ20141126

Country / Region Tags: 
General Topic Tags: 
Problem, Solution, SitRep, or ?: 

Government accused of failing to provide emergency care for British ebola volunteers

THE TELEGRAPH   By Colin Freeman                                                                                         Nov. 26, 2014British medics who have volunteered to fight the Ebola outbreak in Sierra Leone have accused the Government of failing to offer them proper emergency back-up if they get infected.

The government is planning to despatch up to 1,500 NHS volunteers to the west African nation over coming months, as part of a £125m aid programme that a force of 800 British troops began rolling out last month.

But officials have refused to guarantee that any medic who catches the virus will be flown back to Britain for treatment, insisting that most cases can be dealt by a British army clinic that has been set up in the capital, Freetown.

The ruling has caused disquiet among some medics, who point out that the British army facility is not equipped with either kidney dialysis machines or artificial lungs, both of which could be necessary for treatment of anyone with advanced Ebola symptoms.

General Topic Tags: 
Problem, Solution, SitRep, or ?: 

The Race for an Ebola Vaccine

Description of efforts by the big drug companies to develop an Ebloa vaccine
THE NEW YORKER    By Vauhine Vara                        Nov. 25, 2014

"...why this race to create an Ebola vaccine among Merck, GlaxoSmithKline, and Johnson & Johnson—three of the world’s biggest drug manufacturers? For years, pharmaceutical companies didn’t invest much in vaccines, partly because they were so costly and complicated to produce: they’re often made out of live bacteria, which are notoriously difficult to work with. But, over the past several years, companies have realized that the difficulties of making vaccines could be an asset, because they can make it more difficult for generic-drug companies to create copycat versions than for prescription drugs. The vaccine market has also been growing more quickly than the prescription-drug market. The World Health Organization estimates, based on various sources, that global vaccine sales rose from five billion dollars in 2000 to twenty-four billion dollars last year...."

Read complete article
http://www.newyorker.com/business/currency/race-ebola-vaccine

General Topic Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Guinea
howdy folks
Page loaded in 0.611 seconds.